Skip to content

Ambulant versus unattended & attended office versus self-home blood pressure measurement

Ambulant versus unattended & attended office versus self-home blood pressure measurement - AMUSE-BP

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
NL-OMON
Registry ID
NL-OMON55589
Enrollment
120
Registered
2019-09-11
Start date
2020-02-10
Completion date
Unknown
Last updated
2025-03-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension en high blood pressure

Interventions

None listed

Sponsors

Universitair Medisch Centrum Utrecht
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1. Age of 18 years or older 2. Documented medical history of hypertension in local hospital electronic patient record 3. Stable dose of anti-hypertensive medication for at least 2 months (includes no current antihypertensive medication, diagnosis hypertension is enough) 4. SBP>90 and 60 and

Exclusion criteria

Exclusion criteria: 1. SBP >180 mmHg and/or DBP >110mmHg at inclusion screening visit (attended AOBP). 2. Any BP that according to the treating physician is not adequately controlled and needs medication adjustment

Design outcomes

Primary

MeasureTime frame
Main study parameters/endpoints: The main study parameters are twofold: (1) Mean difference between HBPM and ABPM values calculated with the Bland-Altman method (2) Mean standard deviation (SD) of the mean difference between HBPM and ABPM calculated with the Bland-Altman method. - Both expressed in mmHg for both SB and DBP (see primary objective chapter 2). - The HBPM value is a 7-day average of systolic and diastolic BP - The ABPM value is an average BP measured by 24-hour ambulatory measurements

Secondary

MeasureTime frame
For all of the secondary objectives formulated in chapter 2 (objective A, B, C, D, E, F, G, H, I, J) the study parameters are the same as the main study parameters. For the last secondary objectives K the study parameters are: K: To investigate if a different protocol than the standard 7-day HBPM protocol results in clinically acceptable (

Countries

Netherlands

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)